From the Chair

From the Chair: What’s the Best Way to Treat Metastatic Renal Cell Cancer?

Renal cell carcinoma (RCC) accounts for 2% to 3% of all adult malignancies.1,2 It is the most common type of kidney cancer in adults, responsible for approximately 90% to 95% of cases. Approximately, one-third of patients with RCC present, at the time of diagnosis, with metastatic disease. In addition, approximately one-third of patients who present with localized disease also end ... Read More »

From the Chair: Partial versus Radical Nephrectomy for Kidney Cancer: Comparative Effect on Kidney Function

Ajay K. Singh, MBBS, FRCP, MBA Brigham and Women’s Hospital and Harvard Medical School  Boston, Massachusetts In 2017, there were approximately 64,000 new cases of kidney cancer in the United States1, representing nearly 4% of all cancer cases. Patients with kidney cancer are usually evaluated for surgical management unless the cancer is advanced. The traditional surgical approach has been a ... Read More »

From the Chair: Home Dialysis Takes a Big Step

Ajay K. Singh, MBBS, FRCP, MBA Brigham and Women’s Hospital and Harvard Medical School  Boston, Massachusetts From the early days of hemodialysis, many, including the late Dr. Bernard Scribner at the University of Seattle, worked tirelessly to promote home hemodialysis. In the early 1970s, the use of home hemodialysis peaked, with nearly 40% of all patients in the United States ... Read More »

From the Chair: The New Mineral and Bone Disorder Guideline Update: Osteoporosis and Fracture Risk

Ajay K. Singh, MBBS, FRCP, MBA Brigham and Women’s Hospital and Harvard Medical School Boston, Massachusetts Fractures in chronic kidney disease (CKD) patients, particularly those that are elderly, have substantial morbidity and mortality. The Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder (KDIGO CKD-MBD)1, ... Read More »

From the Chair: Managing Nonvalvular Atrial Fibrillation in Dialysis Patients: What Should You Do?

Ajay K. Singh, MBBS, FRCP, MBA The Controversies in Nephrology series1-7 in the Clinical Journal of the American Society of Nephrology (CJASN) covered a topic that virtually every nephrologist has had to wrestle with, namely how to manage a dialysis patient who develops nonvalvular atrial fibrillation (NVAF). The articles are outstanding and thoughtful. A stroke from NVAF could have devastating ... Read More »